CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 387626-387750 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T45616","span":{"begin":0,"end":124},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore we investigated the use of a synthetic cannabinoid agonist, R(+)WIN55,212 with which to treat ongoing EAE disease."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T11","span":{"begin":0,"end":124},"obj":"Sentence"}],"text":"Therefore we investigated the use of a synthetic cannabinoid agonist, R(+)WIN55,212 with which to treat ongoing EAE disease."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T728","span":{"begin":112,"end":115},"obj":"Phenotype"}],"attributes":[{"id":"A728","pred":"hp_id","subj":"T728","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"Therefore we investigated the use of a synthetic cannabinoid agonist, R(+)WIN55,212 with which to treat ongoing EAE disease."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2496","span":{"begin":112,"end":115},"obj":"Disease"},{"id":"T2466","span":{"begin":112,"end":115},"obj":"Disease"}],"attributes":[{"id":"A2496","pred":"mondo_id","subj":"T2496","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A2497","pred":"mondo_id","subj":"T2496","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A2498","pred":"mondo_id","subj":"T2496","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A52476","pred":"mondo_id","subj":"T2466","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A43023","pred":"mondo_id","subj":"T2466","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A68838","pred":"mondo_id","subj":"T2466","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"}],"text":"Therefore we investigated the use of a synthetic cannabinoid agonist, R(+)WIN55,212 with which to treat ongoing EAE disease."}